Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 7
Submit an article Journal homepage
172
Views
2
CrossRef citations to date
0
Altmetric
Commentaries

Myeloma of the central nervous system – an ongoing conundrum!

Simon J. HarrisonThe Peter MacCallum Cancer Centre, East Melbourne and Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Correspondence[email protected]
,
Andrew SpencerThe Alfred Hospital, Melbourne, Australia;
&
Hang QuachSt Vincent’s Hospital, Melbourne, Australia
Pages 1505-1506 | Received 11 Jan 2016, Accepted 10 Feb 2016, Published online: 21 Mar 2016

References

  • Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–2520.
  • Majd M, Wei X, Demopoulos A, et al. Characterization of central nervous system multiple myeloma in the era of novel therapies. Leuk Lymphoma. 2016. [Epub ahead of print]. DOI:10.3109/10428194.2015.1122786. This issue.
  • Nieuwenhuizen L, Biesma DH. Central nervous system myelomatosis: review of the literature. Eur J Haematol. 2008;80:1–9.
  • Blade J, Fernandez de Larrea C, Rosinol L, et al. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol. 2011;29:3805–3812.
  • Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012;12:335–348.
  • Keats JJ, Chesi M, Egan JB, et al. Clonal competition with alternating dominance in multiple myeloma. Blood. 2012;120:1067–1076.
  • Lee D, Kalff A, Low M, et al. Central nervous system multiple myeloma-potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains. Br J Haematol. 2013;162:371–375.
  • Katodritou E, Terpos E, Kastritis E, et al. Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience. Ann Hematol. 2015;94:2033–2042.
  • Lasocki A, Gangatharan S, Gaillard F, et al. Intracranial involvement by multiple myeloma. Clin Radiol. 2015;70:890–897.
  • Villa D, Connors JM, Shenkier TN, et al. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol. 2010;21:1046–1052.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.